Company profile

Teva Pharmaceutical Industries

Generics + branded

TEVA · NYSE · Israel

Share price · TEVA

$36.58+2.55 (+7.49%) 3M

close as of 2026-08-18 · 24h delayed · vol 4.9M

Loading chart…

Prices are end-of-day (EOD), delayed by 24 hours · Unadjusted for historical splits · Data via Databento

Assets

(8 total)
8Total Assets
5Approved
2Phase 3 / Filed
1Phase 1–2 / Early
6Diseases
Quick filter:
Showing 8 of 8 assets
Target & Modality
Beclomethasone (QVAR)
Approved
Glucocorticoid receptorSmall molecule
Asthma
Copaxone
Approved
Myelin basic protein-mimetic immunomodulationPeptide
Multiple Sclerosis
Rasagiline (Azilect)(Azilect)
Approved
MAO-BSmall molecule
Parkinson's DiseaseSchizophrenia
Risperidone (Uzedy)(Uzedy)
Approved
Dopamine D2 and serotonin 5-HT2A receptors (antagonist)Small molecule
Schizophrenia
Tiagabine
Approved
GABA transporter (uptake carrier)Small molecule
Epilepsy
duvakitug
Phase 3
TL1AMonoclonal antibody
Inflammatory Bowel Disease
Ulcerative Colitis, Crohn's Disease
Olanzapine (TV-44749)
Phase 3
Dopamine D2 and serotonin 5-HT2A receptors (antagonist) · Dopamine D2 and serotonin 5-HT2A/5-HT2C receptors (antagonist)Small molecule
Schizophrenia
Anle138bNo recent activity
Phase 1
alpha-synuclein oligomersSmall molecule
Parkinson's Disease

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Insider transactions

Research

Unlock insider transactions

Research includes SEC Form 4 insider transactions — filed buys, sells, awards and exercises linked to the underlying filings.

Institutional holders

Research

Unlock institutional holders

Research includes quarterly SEC 13F institutional ownership — top holders, aggregate positions and quarter-over-quarter context.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.